The field of epilepsy management has seen significant advancements in recent years. This article aims to provide healthcare professionals with a comprehensive update on these developments, to enhance patient care and outcomes.
New antiepileptic drugs (AEDs) have been introduced, offering improved efficacy and tolerability. These include brivaracetam, perampanel, and eslicarbazepine. Brivaracetam has shown promise in controlling focal seizures, while perampanel is effective for both focal and primary generalized tonic-clonic seizures. Eslicarbazepine offers a once-daily dosing option and fewer side effects.
Neuromodulation techniques such as Vagus Nerve Stimulation (VNS), Responsive Neurostimulation (RNS), and Deep Brain Stimulation (DBS) have gained acceptance for drug-resistant epilepsy. VNS involves electrical stimulation of the vagus nerve, RNS monitors brain activity and delivers electrical pulses to prevent seizures, while DBS targets specific brain areas.
Minimally invasive surgical techniques, such as laser interstitial thermal therapy (LITT) and stereotactic EEG-guided radiofrequency thermocoagulation (SEEG-RFTC), have revolutionized epilepsy surgery. LITT uses laser-induced heat to ablate seizure foci, and SEEG-RFTC employs radiofrequency energy for the same purpose, both minimizing brain tissue damage.
Genomic medicine has improved our understanding of epilepsy's genetic basis, enabling personalized treatment strategies. Next-generation sequencing technologies have identified numerous epilepsy-associated genes, facilitating early diagnosis and targeted therapy.
These advancements in epilepsy management are transforming patient care, improving seizure control, and enhancing quality of life. It is crucial for healthcare professionals to stay updated with these developments to deliver optimal patient care. Further research will undoubtedly usher in more breakthroughs in this field.
1.
Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.
2.
Glioblastoma treatment breakthrough shows promise
3.
Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?
4.
Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors
5.
Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care
1.
The Latest Research on Wiskott Aldrich Syndrome
2.
Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer
3.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
4.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
5.
Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
2.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
3.
Efficient Management of First line ALK-rearranged NSCLC - Part V
4.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
5.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation